Drug Companies: FDA’s Rare Disease Hub to Boost Innovation
Drug companies gain from FDA's Rare Disease Innovation Hub, boosting development and commercialization of treatments for rare diseases with enhanced support.Drug companies gain from FDA's Rare Disease Innovation Hub, boosting development and commercialization of treatments for rare diseases with enhanced support.